These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16025970)

  • 1. [Clinical study on integrative medicine for preventing and treating post-transcatheter arterial chemoembolization].
    Feng YL; Ling CQ; Li B
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jun; 25(6):534-6. PubMed ID: 16025970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new way: alleviating postembolization syndrome following transcatheter arterial chemoembolization.
    Yinglu F; Changquan L; Xiaofeng Z; Bai L; Dezeng Z; Zhe C
    J Altern Complement Med; 2009 Feb; 15(2):175-81. PubMed ID: 19216654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ginsenosides combined with dexamethasone in preventing and treating postembolization syndrome following transcatheter arterial chemoembolization: a randomized, controlled and double-blinded prospective trial].
    Feng YL; Ling CQ; Zhu DZ; Yu CQ; Chen Z; Li B
    Zhong Xi Yi Jie He Xue Bao; 2005 Mar; 3(2):99-102. PubMed ID: 15763053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ginsenosides and dexamethasone in managing the liver injury and renal function after transcatheter arterial chemoembolization for hepatic carcinoma patient].
    Feng YL; Ling CQ; Chen Z; Li B; Gu W
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):844-7. PubMed ID: 17416007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jian Pi Li Qi Decoction Alleviated Postembolization Syndrome Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Xu L; Wang S; Zhuang L; Lin J; Chen H; Zhu X; Bei W; Zhao Q; Wu H; Meng Z
    Integr Cancer Ther; 2016 Sep; 15(3):349-57. PubMed ID: 26590124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hepatic functional reserve injury after TACE in hepatocellular carcinoma with Chinese herbal medicines].
    Chen XX; Zhang B; Zhang YQ; Hung GX; Chen MS; Guo RP; Lin XJ; Hu PL; Qiu HJ; Xu BP
    Ai Zheng; 2002 May; 21(5):547-9. PubMed ID: 12452052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized placebo-controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization.
    Ogasawara S; Chiba T; Ooka Y; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Nagai K; Nakagawa T; Sugawara T; Hanaoka H; Kanai F; Yokosuka O
    Hepatology; 2018 Feb; 67(2):575-585. PubMed ID: 28746788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary hepatocarcinoma treated by traditional Chinese medicine combined with transcatheter arterial chemoembolization].
    Hou EC; Lu YX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Mar; 29(3):225-7. PubMed ID: 19548439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Postembolization Syndrome After Transcatheter Arterial Chemoembolization.
    Arslan M; Degirmencioglu S
    Curr Med Imaging Rev; 2019; 15(4):380-385. PubMed ID: 31989907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone Prophylaxis to Alleviate Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Study.
    Yang H; Seon J; Sung PS; Oh JS; Lee HL; Jang B; Chun HJ; Jang JW; Bae SH; Choi JY; Yoon SK
    J Vasc Interv Radiol; 2017 Nov; 28(11):1503-1511.e2. PubMed ID: 28941589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of Jinlong Capsule on expressions of interleukin-2 and soluble interleukin-2 receptor in patients with primary liver cancer after transarterial chemoembolization therapy].
    Zhang HJ; Yang JJ; Wang WX; Jiang X; Mao YJ; Yang CA; Guo JX
    Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):907-10. PubMed ID: 18782532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety analysis of dexamethasone + palonosetron in prevention of post-embolization syndrome after D-TACE: A retrospective study.
    Lu H; Zheng C; Liang B; Xia X
    Medicine (Baltimore); 2023 Oct; 102(40):e35433. PubMed ID: 37800841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting post-embolization fever and liver failure after trans-arterial chemo-embolization in a cohort without background infective hepatitis- a prospective analysis.
    Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage CA; Upasena A; Sirigampala C; de Silva HJ
    BMC Gastroenterol; 2015 Aug; 15():96. PubMed ID: 26239844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A controlled clinical study between hepatic arterial infusion with embolized curcuma aromatic oil and chemical drugs in treating primary liver cancer].
    Cheng JH; Chang G; Wu WY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Mar; 21(3):165-7. PubMed ID: 12577327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to prophylactically alleviate postembolization syndrome following transarterial chemoembolization?: Protocol of a double blinded, randomized, placebo-controlled trial.
    Pan Y; Chang R; He Z; Hong M
    Medicine (Baltimore); 2021 Apr; 100(14):e25360. PubMed ID: 33832116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis: therapeutic effect of transcatheter arterial chemoembolization combined with compound kushen injection in hepatocellular carcinoma.
    Sun Q; Ma W; Gao Y; Zheng W; Zhang B; Peng Y
    Afr J Tradit Complement Altern Med; 2012; 9(2):178-88. PubMed ID: 23983333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
    Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
    Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined transcatheter arterial chemoembolization and beta-ultrasound guided portal vein embolization in the treatment of hepatocellular carcinoma.
    Mao G; Yu Z; Zhang Y; Cheng J
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):391-3. PubMed ID: 12408773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
    Yu Y; Lang Q; Chen Z; Li B; Yu C; Zhu D; Zhai X; Ling C
    Cancer; 2009 Nov; 115(22):5132-8. PubMed ID: 19672999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of postoperative antiviral combined transcatheter arterial chemoembolization therapy in prevention of hepatitis B-related hepatocellular carcinoma recurrence.
    Yan Q; Ni J; Zhang GL; Yao X; Yuan WB; Zhou L; Zheng SS
    Chin Med J (Engl); 2013 Mar; 126(5):855-9. PubMed ID: 23489790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.